Western Section AUA - 2018 Annual Meeting - October 28 to November 2

Print Friendly, PDF & Email

Copy of Copy of Copy of STATE OF ARTIndustry-sponsored symposia are separate from the Western Section AUA programming. The Western Section AUA is not a sponsor and assumes no responsibility or liability for the educational program or its content. These symposia have been approved to be conducted during the meeting to provide attendees with optional educational opportunities at their discretion.

 

 

.

Please RSVP via email or sign-up in advance on-site at the hotel


MONDAY, OCT. 29
 
Breakfast SYMPOSIUM
6:15 AM - 7:30 AM
Bela Denes, MD, VP, Medical Affairs, Blue Earth Diagnostics, Inc - “Detecting and Localizing Recurrent Prostate Cancer with Axumin® (Fluciclovine F 18) Injection”.
Supported by Blue Earth Diagnostics, Inc


MONDAY, OCT. 29

Lunch SYMPOSIUM
12:30 PM - 1:30 PM
William Aronson, MD, Professor, UCLA Department of Urology, Chief of Urology at the UCLA/Olive View Medical Center - “A Treatment Option for Castration-Resistant Prostate Cancer (CRPC)”.
Supported by Astellas / Pfizer Oncology


TUESDAY, OCT. 30

Lunch SYMPOSIUM
12:15 PM - 1:25 PM
Mark A. Moyad, MD, Jenkins/Pokempner Director of Preventive & Alternative Medicine, University of Michigan Medical Center, Dept. of Urology - "Promoting Wellness".
Supported by Abbvie


WEDNESDAY, OCT. 31

Breakfast SYMPOSIUM
6:15 AM - 7:30 AM
Sia Daneshmand, MD, Associate Professor of Urology (Clinical Scholar), Director of Urologic Oncology, Director of Clinical Research, Urologic Oncology Fellowship Director, USC/Norris Comprehensive Cancer Center, Institute of Urology - "Advances in the Diagnosis of Bladder Cancer".
Supported by Pacific Edge Diagnostics


WEDNESDAY, OCT. 31

Lunch SYMPOSIUM
12:00 PM - 1:15 PM
Robert Reiter, MD, Professor, Urology, Molecular Biology, Director of the Prostate Cancer Program, UCLA. ERLEADA™ (apalutamide): For the Treatment of Patients With Non-Metastatic Castration-Resistant Prostate Cancer (CRPC).
Supported by Janssen